Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of germline polymorphisms in predicting concurrent chemoradiotherapy response in esophageal cancer.

International journal of radiation oncology, biology, physics - 1 Apr 2012

Chen Pei-Chun, Chen Yen-Ching, Lai Liang-Chuan, Tsai Mong-Hsun, Chen Shin-Kuang, Yang Pei-Wen, Lee Yung-Chie, Hsiao Chuhsing K, Lee Jang-Ming, Chuang Eric Y

Abstract excerpt

PURPOSE: To identify germline polymorphisms to predict concurrent chemoradiation therapy (CCRT) response in esophageal cancer patients. MATERIALS AND METHODS: A total of 139 esophageal cancer patients treated with CCRT (cisplatin-based chemotherapy combined with 40 Gy of irradiation) and subsequent esophagectomy were recruited at the National Taiwan University Hospital between 1997 and 2008. After excluding...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemoradiotherapy
Share to Chromosomes, Human, Pair 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cisplatin

Share to Esophageal Neoplasms

Share to Fluorouracil

Share to Radiotherapy Dosage

Share to Remission Induction

Share to Taiwan

Source

Identifiers

PMID: 21596488
DOI: 10.1016/j.ijrobp.2011.02.036

Genes

FARSB
SGPP2
ZRANB3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of germline polymorphisms in predicting concurrent chemoradiotherapy response in esophageal cancer.PMID 21596488Read ↗

GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma.Semantic proximity Read ↗

Esophageal cancer: Risk factors, genetic association, and treatment.Semantic proximity Read ↗

Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy.Semantic proximity Read ↗

Characteristics and response to next-generation sequencing-guided therapy in locally advanced or metastatic esophageal cancer.Semantic proximity Read ↗

Genetic variants in DNA repair predicts the survival of patients with esophageal cancer.Semantic proximity Read ↗

Association of miRNA-related genetic polymorphisms and prognosis in patients with esophageal squamous cell carcinoma.Semantic proximity Read ↗

ERCC1 single nucleotide polymorphism C8092A, but not its expression is associated with survival of esophageal squamous cell carcinoma patients from Fujian province, China.Semantic proximity Read ↗

Predictive genetic markers in neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: a long way to go. Review of the literature.Semantic proximity Read ↗

Relevance of Pharmacogenetic Polymorphisms With Response to Docetaxel, Cisplatin, and 5-Fluorouracil Chemotherapy in Esophageal Cancer.Semantic proximity Read ↗

Genetic variants in DNA repair pathway genes and risk of esophageal squamous cell carcinoma and gastric adenocarcinoma in a Chinese population.Semantic proximity Read ↗

A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.Semantic proximity Read ↗

Multiregion sequencing reveals the genetic correlation of esophageal squamous cell carcinoma and matched cell-free DNASemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.